|
1
|
Jain RK: Normalization of tumor
vasculature: An emerging concept in antiangiogenic therapy.
Science. 307:58–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Potente M, Gerhardt H and Carmeliet P:
Basic and therapeutic aspects of angiogenesis. Cell. 146:873–887.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jain RK: Antiangiogenesis strategies
revisited: From starving tumors to alleviating hypoxia. Cancer
Cell. 26:605–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carretero R, Sektioglu IM, Garbi N,
Salgado OC, Beckhove P and Hämmerling GJ: Eosinophils orchestrate
cancer rejection by normalizing tumor vessels and enhancing
infiltration of CD8(+) T cells. Nat Immunol. 16:609–617. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peterson TE, Kirkpatrick ND, Huang Y,
Farrar CT, Marijt KA, Kloepper J, Datta M, Amoozgar Z, Seano G,
Jung K, et al: Dual inhibition of Ang-2 and VEGF receptors
normalizes tumor vasculature and prolongs survival in glioblastoma
by altering macrophages. Proc Natl Acad Sci USA. 113:pp. 4470–4475.
2016; View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Bock K, Georgiadou M, Schoors S,
Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquière B,
Cauwenberghs S, Eelen G, et al: Role of PFKFB3-driven glycolysis in
vessel sprouting. Cell. 154:651–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Polet F and Feron O: Endothelial cell
metabolism and tumour angiogenesis: Glucose and glutamine as
essential fuels and lactate as the driving force. J Intern Med.
273:156–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cruys B, Wong BW, Kuchnio A, Verdegem D,
Cantelmo AR, Conradi LC, Vandekeere S, Bouché A, Cornelissen I,
Vinckier S, et al: Glycolytic regulation of cell rearrangement in
angiogenesis. Nat Commun. 7:122402016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, An X, Guo X, Habtetsion TG, Wang Y,
Xu X, Kandala S, Li Q, Li H, Zhang C, et al: Endothelial PFKFB3
plays a critical role in angiogenesis. Arterioscler Thromb Vasc
Biol. 34:1231–1239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cantelmo AR, Conradi LC, Brajic A, Goveia
J, Kalucka J, Pircher A, Chaturvedi P, Hol J, Thienpont B, Teuwen
LA, et al: Inhibition of the glycolytic activator PFKFB3 in
endothelium induces tumor vessel normalization, impairs metastasis
and improves chemotherapy. Cancer Cell. 30:968–985. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Bock K, Georgiadou M and Carmeliet P:
Role of endothelial cell metabolism in vessel sprouting. Cell
Metab. 18:634–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schoors S, De Bock K, Cantelmo AR,
Georgiadou M, Ghesquière B, Cauwenberghs S, Kuchnio A, Wong BW,
Quaegebeur A, Goveia J, et al: Partial and transient reduction of
glycolysis by PFKFB3 blockade reduces pathological angiogenesis.
Cell Metab. 19:37–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Francesco L, Dovizio M, Trenti A,
Marcantoni E, Moore A, O'Gaora P, McCarthy C, Tacconelli S, Bruno
A, Alberti S, et al: Dysregulated post-transcriptional control of
COX-2 gene expression in gestational diabetic endothelial cells. Br
J Pharmacol. Jul 3–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leahy KM, Ornberg RL, Wang Y, Zweifel BS,
Koki AT and Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib
reduces proliferation and induces apoptosis in angiogenic
endothelial cells in vivo. Cancer Res. 62:625–631. 2002.PubMed/NCBI
|
|
15
|
Sui W, Zhang Y, Wang Z, Wang Z, Jia Q, Wu
L and Zhang W: Antitumor effect of a selective COX-2 inhibitor,
celecoxib, may be attributed to angiogenesis inhibition through
modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murine
hepatocarcinoma model. Oncol Rep. 31:2252–2260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaul C: Aspirin for migraine in pregnancy.
This recommendation seems questionable. MMW Fortschr Med.
155:172013.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salvado MD, Alfranca A, Haeggström JZ and
Redondo JM: Prostanoids in tumor angiogenesis: Therapeutic
intervention beyond COX-2. Trends Mol Med. 18:233–243. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bijman MN, Hermelink CA, van Berkel MP,
Laan AC, Janmaat ML, Peters GJ and Boven E: Interaction between
celecoxib and docetaxel or cisplatin in human cell lines of ovarian
cancer and colon cancer is independent of COX-2 expression levels.
Biochem Pharmacol. 75:427–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Francesco L, Totani L, Dovizio M,
Piccoli A, Di Francesco A, Salvatore T, Pandolfi A, Evangelista V,
Dercho RA, Seta F and Patrignani P: Induction of prostacyclin by
steady laminar shear stress suppresses tumor necrosis factor-alpha
biosynthesis via heme oxygenase-1 in human endothelial cells. Circ
Res. 104:506–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Groot DJ, de Vries EG, Groen HJ and de
Jong S: Non-steroidal anti-inflammatory drugs to potentiate
chemotherapy effects: From lab to clinic. Crit Rev Oncol Hematol.
61:52–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burleigh ME, Babaev VR, Yancey PG, Major
AS, McCaleb JL, Oates JA, Morrow JD, Fazio S and Linton MF:
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in
ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol. 39:443–452.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshida S, Amano H, Hayashi I, Kitasato H,
Kamata M, Inukai M, Yoshimura H and Majima M: COX-2/VEGF-dependent
facilitation of tumor-associated angiogenesis and tumor growth in
vivo. Lab Invest. 83:1385–1394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu G, Luo J, Rana JS, Laham R, Sellke FW
and Li J: Involvement of COX-2 in VEGF-induced angiogenesis via P38
and JNK pathways in vascular endothelial cells. Cardiovasc Res.
69:512–519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vandekeere S, Dewerchin M and Carmeliet P:
Angiogenesis revisited: An overlooked role of endothelial cell
metabolism in vessel sprouting. Microcirculation. 22:509–517. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goveia J, Stapor P and Carmeliet P:
Principles of targeting endothelial cell metabolism to treat
angiogenesis and endothelial cell dysfunction in disease. EMBO Mol
Med. 6:1105–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eelen G, de Zeeuw P, Simons M and
Carmeliet P: Endothelial cell metabolism in normal and diseased
vasculature. Circ Res. 116:1231–1244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun CM, Xiong DB, Yan Y, Geng J, Liu M and
Yao XD: Genetic alteration in phosphofructokinase family promotes
growth of muscle-invasive bladder cancer. Int J Biol Markers.
31:e286–e293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schoors S, Bruning U, Missiaen R, Queiroz
KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia
J, et al: Fatty acid carbon is essential for dNTP synthesis in
endothelial cells. Nature. 520:192–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
